Communication Address:
Solara Active Pharma Sciences Limited
2nd Floor, Admin Block
27, Vandaloor Kelambakkam Road, Keelakottaiyur Village, Melakottaiyur (Post) Chennai - 600 127, India
Tel : +91 44 43446700
Fax : +91 44 47406190
E-mail : investors@solara.co.in www.solara.co.in
December 22, 2022
National Stock Exchange of India Limited
Exchange Plaza, Bandra-Kurla Complex
Bandra (E), Mumbai - 400 051
Kind Attn: Mr. Binoy Yohannan
Associate Vice President
Surveillance
Dear Sir,
Sub: Significant increase in volume
Ref: Your letter dated 21.12.2022, with reference: NSE/CM/Surveillance/12640
We refer to your above letter seeking clarification on the significant increase in volume in the securities of the Company across exchanges in the recent past.
We wish to clarify that Company has made all the required disclosures pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and has not withheld any material information/event that, in our opinion, would have a bearing on the price/volume behaviour in the scrip.
Kindly take the same on record.
Thanking you,
Yours faithfully,
For Solara Active Pharma Sciences Limited
SUDDAPALLI MURALIKRISHNA
Digitally signed by SUDDAPALLI MURALIKRISHNA
Date: 2022.12.22 10:22:35 +05'30'
S. Murali Krishna
Company Secretary
Solara Active Pharma Sciences Limited - CIN : L24230MH2017PLC291636
REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Solara Active Pharma Sciences Ltd. published this content on 22 December 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 December 2022 05:21:03 UTC.